Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Silymarin Supplementation on Graft Function and Early Post-transplant Complications

NCT06801886 is registered in ClinicalTrials.gov with University Hospital, Martin as lead sponsor.

NCT NCT06801886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06801886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Silymarin Supplementation on Graft Function and Early Post-transplant Complications
Lead sponsor
University Hospital, Martin
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
January 7, 2020
Completion date
December 31, 2025
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft rejection, antibody mediated rejection of kidney transplant, arterial hypertension, chronic kidney disease, biopsy proven acute rejection, posttransplant diabetes mellitus